Date published: 2026-3-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

UPIIIa Inhibitors

UPIIIa inhibitors are a class of chemical compounds that primarily target and interact with the protein known as Uroplakin IIIa (UPIIIa). UPIIIa is a crucial component of urothelial cells, which line the urinary tract, and plays a vital role in maintaining the structural integrity and functionality of these cells. UPIIIa inhibitors are designed to modulate the activity of this specific protein, making them a subject of interest in the field of urology and related research areas.

These inhibitors typically function by binding to UPIIIa, altering its conformation or activity, and thereby affecting the normal functioning of urothelial cells. While the exact mechanisms of UPIIIa inhibition can vary among different compounds within this class, the overarching goal is to manipulate UPIIIa in a way that can have potential implications in the context of urothelial health. Understanding the structure and function of UPIIIa inhibitors is crucial for researchers and scientists aiming to gain insights into the intricate biology of the urinary tract.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Isoflavone compound that can inhibit tyrosine kinases, which may affect signaling pathways related to cell adhesion and integrity, thus indirectly affecting UPIIIa function.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

Src family kinase inhibitor that can disrupt signaling pathways involved in cytoskeletal organization and might impact the cellular distribution of UPIIIa.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor that can lead to similar effects as LY294002, potentially altering UPIIIa dynamics.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor that can interfere with the MAPK/ERK pathway, which may regulate processes affecting UPIIIa.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Also a MEK inhibitor, U0126 can modulate the MAPK/ERK pathway, and consequently affect UPIIIa's role in the urothelium.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that might alter stress response pathways, potentially influencing UPIIIa function.

SB 202190

152121-30-7sc-202334
sc-202334A
sc-202334B
1 mg
5 mg
25 mg
$31.00
$128.00
$454.00
45
(1)

A selective inhibitor of Gs-alpha subunit of G proteins, which might influence signaling pathways impacting UPIIIa.

Gö 6976

136194-77-9sc-221684
500 µg
$227.00
8
(1)

A potent inhibitor of conventional calcium-dependent protein kinases, which could affect pathways regulating UPIIIa.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor that can disrupt actin cytoskeleton dynamics, potentially influencing the membrane localization of UPIIIa.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

Casein kinase 1 inhibitor that might affect the phosphorylation status of proteins involved in the pathways regulating UPIIIa.